Cui Y#, Song M#, Tie J#, Li S#, Wang H, Zhang Y, Geng J, Liu Z, Teng H, Sui X, Zhu X, Cai Y, Li Y*, Wang W*. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.,Journal of Cancer Research and Clinical Oncology,150(4):176

Cui Y#, Liu X#, Li S#, Wang H, Xiang Y, Zhang Y, Song M, Geng J, Liu Z, Teng H, Zhu X, Cai Y, Li Y*, Wang W*. The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0,Clinical & Translational Oncology,26(4):1012-1021

Teng Y#, Ma D#, Yan Y#, Geng J, Liu Z, Zhu X, Li S, Zhang Y, Wang H, Cai Y, Yue H, Li Y*, Wang W*. Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer.,Front Oncol,13:1289824

Zuo L, Nie W, Yu S, Zhuang WR, Liang C, Li S, Shi D, Wu G, Sui X, Li Y*, Xie HY*. Biomimetic Nanovesicle with Mitochondria-Synthesized Sonosensitizer and Mitophagy Inhibition for Cancer Sono-Immunotherapy.,Nano Letters,23(7):3005-3013

Ming J, Du R, Geng J, Li S, Liu Z, Cai Y, Zhu X, Zhang Y, Wang H, Wang Z, Tang L, Zhang X, Peng Z, Wu A, Bu Z, Peng Y, Yan Y, Li Z, Li Y*, Li Z*, Wang W*. Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy,Front Nutr,10:988632

Song M#, Wang H#, Wang L, Li S, Zhang Y, Geng J, Zhu X, Li Y*, Cai Y*, Wang W*. Dentate line invasion as a predictive factor of poor distant relapse-free survival in locally advanced lower rectal cancer with anal sphincter involvement.,BMC Cancer,2022;22(1):1196

Du R#, Ming J#, Geng J#, Zhu X, Zhang Y, Li S, Liu Z, Wang H, Wang Z, Tang L, Zhang X, Wu A, Bu Z, Yan Y, Li Z, Li Y*, Li Z*, Wang W*. Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study.,Radiat Oncol.,2022;17(1):45

Zuo L, Nie W, Yu S, Zhuang W, Wu G, Liu H, Huang L, Shi D, Sui X, Li Y*, Xie HY*. Smart Tumor-Cell-Derived Microparticles Provide On-Demand Photosensitizer Synthesis and Hypoxia Relief for Photodynamic Therapy.,Angewandte Chemie-International Edition,60(48)25365-25371

Li S#, Dong D#, Geng J, Zhu X, Shi C, Zhang Y, Wang H, Zhou S, Wu H, Cai Y, Li Y*, Wang W*. Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer,Asia-Pacific Journal of Clinical Oncology,2021: 13577

Ji D#, Song C#, Li Y#, Xia J#, Wu Y#, Jia J, Cui X, Yu S, Gu J*. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer,J Immunother Cancer,8(2):e000826

Geng JH#, Zhang YZ#, Li YH#, Li S, Wang L, Wang ZL, Zhu XG, Bu ZD, Li ZY, Su XQ, Cai Y, Wu AW*, Wang WH*. Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes,Annals of Translational Medicine,9(3):217

放射治疗装备质量评价技术和临床应用质量保障体系构建, 子课题负责人, 2022.11.1～2025.10.31, 国家重点研发计划

基于临床的放射治疗设备和新技术测试方法评价研究, 子课题负责人, 2022.11.1～2025.10.31, 国家重点研发计划

特瑞普利单抗注射液（Toripalimab）联合术前放化疗治疗局部晚期胃食管结合部腺癌的探索性研究, 课题负责人, 2020.5.1～2023.5.31, 首都卫生发展科研专项

局部晚期直肠癌术前放疗敏感性的研究, 课题负责人, 2018.1.1～2019.12.31, 北京市医管局青苗计划

老年晚期胃癌放疗联合免疫治疗的探索性研究, 课题负责人, 2024.4.1～2025.12.1, 吴阶平医学基金会

消化道肿瘤同期放化疗期间预防应用重组人血小板生成素的研究, 课题负责人, 2018.6.18～2020.3.31, 北京亦度教育科技有限公司

循环肿瘤 DNA 指导中低位局部进展期直肠癌 治疗策略的前瞻性多中心随机对照研究, 子课题负责人, 2024.6.1～2025.9.30, 横向课题

辐射剂量监测可靠性技术研究——辐射场性能验证及应用示范, 参加者, 2018.1.1～2020.9.30, 国家重点研发计划

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式	操作
2025	肿瘤放射治疗学	长学制	专业学位	临床技能训练与研究	长学制二级学科培养